Selected research
Market Structure
Global Comprehensive Rapid Pathogen Diagnostic Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Comprehensive Rapid Pathogen Diagnostic Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Comprehensive Rapid Pathogen Diagnostic Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Comprehensive Rapid Pathogen Diagnostic Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Comprehensive Rapid Pathogen Diagnostic Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Comprehensive Rapid Pathogen Diagnostic Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Comprehensive Rapid Pathogen Diagnostic Solution include Jabil, Biomérieux, Thermo Fisher Scientific, Bio-Rad, Neogen, Wuhan Mingde Biotechnology, Shenzhen BGI, RocGene (Beijing) Scientific Instrument and Beijing Trans Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Comprehensive Rapid Pathogen Diagnostic Solution market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Comprehensive Rapid Pathogen Diagnostic Solution and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Comprehensive Rapid Pathogen Diagnostic Solution revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Comprehensive Rapid Pathogen Diagnostic Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
Comprehensive Rapid Pathogen Diagnostic Solution Segment by Company
Jabil
Biomérieux
Thermo Fisher Scientific
Bio-Rad
Neogen
Wuhan Mingde Biotechnology
Shenzhen BGI
RocGene (Beijing) Scientific Instrument
Beijing Trans Biotechnology
Comprehensive Rapid Pathogen Diagnostic Solution Segment by Type
Based on PCR Technique
Immunology-Based Testing
Others
Comprehensive Rapid Pathogen Diagnostic Solution Segment by Application
Hospital
Clinic
Laboratory
Others
Comprehensive Rapid Pathogen Diagnostic Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Comprehensive Rapid Pathogen Diagnostic Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Comprehensive Rapid Pathogen Diagnostic Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Comprehensive Rapid Pathogen Diagnostic Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Comprehensive Rapid Pathogen Diagnostic Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Comprehensive Rapid Pathogen Diagnostic Solution industry.
Chapter 3: Detailed analysis of Comprehensive Rapid Pathogen Diagnostic Solution companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Comprehensive Rapid Pathogen Diagnostic Solutionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Based on PCR Technique
- Immunology-Based Testing
- Others
Applications
- Hospital
- Clinic
- Laboratory
- Others
Companies covered
- Jabil
- Biomérieux
- Thermo Fisher Scientific
- Bio-Rad
- Neogen
- Wuhan Mingde Biotechnology
- Shenzhen BGI
- RocGene (Beijing) Scientific Instrument
- Beijing Trans Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Based on PCR Technique
- 1.2.3 Immunology-Based Testing
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Laboratory
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Comprehensive Rapid Pathogen Diagnostic Solution Growth Trends by Region
- 1.5.1 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Region (2021-2026)
- 1.5.3 Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Dynamics
- 2.1 Comprehensive Rapid Pathogen Diagnostic Solution Industry Trends
- 2.2 Comprehensive Rapid Pathogen Diagnostic Solution Industry Drivers
- 2.3 Comprehensive Rapid Pathogen Diagnostic Solution Industry Opportunities and Challenges
- 2.4 Comprehensive Rapid Pathogen Diagnostic Solution Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Comprehensive Rapid Pathogen Diagnostic Solution Revenue by Company (2021-2026)
- 3.2 Global Comprehensive Rapid Pathogen Diagnostic Solution Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Comprehensive Rapid Pathogen Diagnostic Solution Key Company Head office and Area Served
- 3.4 Global Comprehensive Rapid Pathogen Diagnostic Solution Company, Product Type & Application
- 3.5 Global Comprehensive Rapid Pathogen Diagnostic Solution Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Comprehensive Rapid Pathogen Diagnostic Solution Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Comprehensive Rapid Pathogen Diagnostic Solution Players Market Share by Revenue in 2025
- 3.6.3 2025 Comprehensive Rapid Pathogen Diagnostic Solution Tier 1, Tier 2, and Tier 3
4 Comprehensive Rapid Pathogen Diagnostic Solution Market by Type
- 4.1 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2021-2032)
- 4.3 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size Share by Type (2021-2032)
5 Comprehensive Rapid Pathogen Diagnostic Solution Market by Application
- 5.1 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2021-2032)
- 5.3 Global Comprehensive Rapid Pathogen Diagnostic Solution Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Jabil
- 6.1.1 Jabil Company Information
- 6.1.2 Jabil Business Overview
- 6.1.3 Jabil Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Jabil Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.1.5 Jabil Recent Developments
- 6.2 Biomérieux
- 6.2.1 Biomérieux Company Information
- 6.2.2 Biomérieux Business Overview
- 6.2.3 Biomérieux Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Biomérieux Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.2.5 Biomérieux Recent Developments
- 6.3 Thermo Fisher Scientific
- 6.3.1 Thermo Fisher Scientific Company Information
- 6.3.2 Thermo Fisher Scientific Business Overview
- 6.3.3 Thermo Fisher Scientific Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Thermo Fisher Scientific Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.3.5 Thermo Fisher Scientific Recent Developments
- 6.4 Bio-Rad
- 6.4.1 Bio-Rad Company Information
- 6.4.2 Bio-Rad Business Overview
- 6.4.3 Bio-Rad Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bio-Rad Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.4.5 Bio-Rad Recent Developments
- 6.5 Neogen
- 6.5.1 Neogen Company Information
- 6.5.2 Neogen Business Overview
- 6.5.3 Neogen Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Neogen Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.5.5 Neogen Recent Developments
- 6.6 Wuhan Mingde Biotechnology
- 6.6.1 Wuhan Mingde Biotechnology Company Information
- 6.6.2 Wuhan Mingde Biotechnology Business Overview
- 6.6.3 Wuhan Mingde Biotechnology Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Wuhan Mingde Biotechnology Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.6.5 Wuhan Mingde Biotechnology Recent Developments
- 6.7 Shenzhen BGI
- 6.7.1 Shenzhen BGI Company Information
- 6.7.2 Shenzhen BGI Business Overview
- 6.7.3 Shenzhen BGI Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Shenzhen BGI Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.7.5 Shenzhen BGI Recent Developments
- 6.8 RocGene (Beijing) Scientific Instrument
- 6.8.1 RocGene (Beijing) Scientific Instrument Company Information
- 6.8.2 RocGene (Beijing) Scientific Instrument Business Overview
- 6.8.3 RocGene (Beijing) Scientific Instrument Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 RocGene (Beijing) Scientific Instrument Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.8.5 RocGene (Beijing) Scientific Instrument Recent Developments
- 6.9 Beijing Trans Biotechnology
- 6.9.1 Beijing Trans Biotechnology Company Information
- 6.9.2 Beijing Trans Biotechnology Business Overview
- 6.9.3 Beijing Trans Biotechnology Comprehensive Rapid Pathogen Diagnostic Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Beijing Trans Biotechnology Comprehensive Rapid Pathogen Diagnostic Solution Product Portfolio
- 6.9.5 Beijing Trans Biotechnology Recent Developments
7 North America
- 7.1 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size (2021-2032)
- 7.2 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type
- 7.2.1 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2021-2026)
- 7.2.2 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2027-2032)
- 7.2.3 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Type (2021-2032)
- 7.3 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application
- 7.3.1 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2021-2026)
- 7.3.2 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2027-2032)
- 7.3.3 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Application (2021-2032)
- 7.4 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country
- 7.4.1 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2021-2026)
- 7.4.3 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2027-2032)
- 7.4.4 North America Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size (2021-2032)
- 8.2 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type
- 8.2.1 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2021-2026)
- 8.2.2 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2027-2032)
- 8.2.3 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Type (2021-2032)
- 8.3 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application
- 8.3.1 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2021-2026)
- 8.3.2 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2027-2032)
- 8.3.3 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Application (2021-2032)
- 8.4 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country
- 8.4.1 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2021-2026)
- 8.4.3 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2027-2032)
- 8.4.4 Europe Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Comprehensive Rapid Pathogen Diagnostic Solution Market Size (2021-2032)
- 9.2 China Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type
- 9.2.1 China Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2021-2026)
- 9.2.2 China Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2027-2032)
- 9.2.3 China Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Type (2021-2032)
- 9.3 China Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application
- 9.3.1 China Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2021-2026)
- 9.3.2 China Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2027-2032)
- 9.3.3 China Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size (2021-2032)
- 10.2 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type
- 10.2.1 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2021-2026)
- 10.2.2 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2027-2032)
- 10.2.3 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Type (2021-2032)
- 10.3 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application
- 10.3.1 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2021-2026)
- 10.3.2 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2027-2032)
- 10.3.3 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Application (2021-2032)
- 10.4 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country
- 10.4.1 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2021-2026)
- 10.4.3 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2027-2032)
- 10.4.4 Asia Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type
- 11.2.1 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application
- 11.3.1 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country
- 11.4.1 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Comprehensive Rapid Pathogen Diagnostic Solution Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst